This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articlesA top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Cerebras hit the market with fireworks, then cooled off quickly. This guide explains what happened, how to value the ...
A major hedge fund exit grabbed headlines as a fund controlled by William Oberndorf liquidated a sizable monday.com s...
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
Alphabet is famous for growth, not income. A new high-yield option—mandatory convertible preferred shares GOOGM and G...
Two popular healthcare ETFs take different paths: VHT offers broad, low-cost exposure to the medical sector, while PP...
Bitcoin holds around the mid-$60k range as weekend tensions in the Middle East collide with expectations of Federal R...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
A legendary investor speculates SpaceX could reach $30 trillion by 2040. This piece breaks down what that would requi...
A Duke University professor warns that Bitcoin's risk profile could shift as derivatives liquidity makes a 51% attack...
If president donald trump just signals a major crypto push, investors face a fast-moving regulatory landscape. This g...
As AI-driven gains fade in 2026, investors face a choice on covered call ETFs. This piece breaks down performance, ri...